Latest Market Positioning News

Nova Eye Medical has reported a record A$29.3 million in FY25 revenue, driven by sustained US growth and operational improvements, setting the stage for breakeven EBITDA in the first half of FY26.

Infragreen Group Ltd has reported a strong FY25 performance, exceeding its prospectus forecasts post-IPO and advancing its footprint in clean energy and waste recovery sectors. The company’s strategic acquisitions and organic growth set the stage for continued momentum into FY26.

Global Health Limited reports solid progress towards profitability in FY2025, driven by a 6% increase in subscription revenue and strategic AI integration across its healthcare platforms.

Electro Optic Systems (EOS) has secured a role in the Australian Defence Force’s $1.3 billion Project LAND 156, aiming to develop advanced counter-drone capabilities over the next decade. Initial orders for EOS’s Slinger remote weapon system could boost revenues from 2026 onwards.

Airtasker Limited is set to release its FY25 financial results on 28 August 2025, accompanied by an investor webinar featuring CEO Tim Fung and CFO Mahendra Tharmarajah. The announcement comes as the company highlights its new partnership with the Visa Cash App Racing Bulls Formula One Team.

Cambium Bio has updated its placement, raising A$2.17 million to fund late-stage clinical trials for its lead ophthalmology product, Elate Ocular®. The capital raise reflects strong investor interest and strategic backing.

archTIS Limited has acquired Spirion LLC’s technology, customers, and employees for A$15.7 million, significantly expanding its U.S. presence and product portfolio in data security. The deal adds A$17 million in annual recurring revenue and brings new cross-selling opportunities across a blue-chip customer base.

Kinatico has reported a robust FY25 with 12% revenue growth to $32.1 million, driven by a 54% surge in SaaS revenue and the launch of its new Kinatico Compliance product. The company’s strong cash flow and expanding market position signal a promising future in the evolving RegTech landscape.

BluGlass Limited reported a 16% rise in revenue to $11.7 million for FY25, driven by key US Department of Defense contracts and new partnerships. However, the company’s net loss increased 8% to nearly $11 million amid ongoing R&D investment and operational scaling.

Pure Foods Tasmania has secured a $400,000 investment from entrepreneurs Jon Kontopos and Matthew Abrahams as part of a broader $750,000 capital raising effort, reinforcing confidence in the company’s turnaround plan ahead of its upcoming shareholder vote.

Neuren Pharmaceuticals reported a robust half-year with an 88% increase in net profit, driven by rising royalties from DAYBUE™ sales and progress in its NNZ-2591 clinical program. The company also completed a $39.6 million share buy-back, underscoring confidence in its growth trajectory.

Metrics Real Estate Multi-Strategy Fund has released its inaugural annual report, revealing a strong start with $41.9 million profit before tax and distributions of 8.21 cents per unit following a $302.8 million IPO. The Fund’s diversified commercial real estate portfolio spans senior loans, mezzanine debt, and equity investments across Australia and New Zealand.